Idebenone

CHEMBL252556 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

338.4 g/mol

LogP

4.3

Phase

4

A synthetic coenzyme Q10 analogue used for rare mitochondrial diseases.

分子量

338.4000 g/mol

LogP

4.30

TPSA

72.80 Å²

リピンスキーの五則

適合

治療領域

Parkinson's Disease Epilepsy Migraine Multiple Sclerosis Stroke

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O

InChI

InChI=1S/C19H30O5/c1-14-15(12-10-8-6-4-5-7-9-11-13-20)17(22)19(24-3)18(23-2)16(14)21/h20H,4-13H2,1-3H3

Molecular Formula

C19H30O5

HBD / HBA

1 / 5

回転可能結合数

12

重原子数

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A synthetic coenzyme Q10 analogue used for rare mitochondrial diseases.

Yes, Idebenone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL252556. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 3686. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Idebenone PillFYIで

構造

クイックデータ

分子式: C19H30O5
同義語: 3

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.